Skip to content

Semi-manual Vessel Density Analysis on Optical Coherence Tomography Angiography Images of Healthy Adults

Semi-manual Vessel Density Analysis on Optical Coherence Tomography Angiography Images of Healthy Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03590899
Enrollment
39
Registered
2018-07-18
Start date
2017-02-01
Completion date
2022-03-30
Last updated
2022-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Purpose of the study is to examine the vessel density of healthy adults' optical coherence tomography angiography images with two semi-manual methods and an automated quantification program.

Detailed description

Optical coherence tomography angiography (OCTA) is a software upgrade on conventional spectral-domain or swept-source optical coherence tomography devices that enables non-invasive, dye-free, three dimensional analysis of the retinal vessels. Vessel density is a very important parameter almost in all retinal disorders. In the recent past, automated quantification software was built into some OCTA devices which can automatically calculate the retinal vessel density as well. In this study two semi-manual techniques are used in order to analyze the vessel density of healthy subjects' OCTA images. Vessel density is also measured with a new automated quantification program, and results of the three methods are compared. OCT machines are approved in the EU and the US and are not experimental devices. The device used in this study is the commercially available Zeiss Cirrus HD OCT Angioplex 5000 that operates with spectral-domain technology.

Interventions

DEVICEOptical coherence tomography angiography (Zeiss Cirrus HD OCT 5000 AngioPlex)

Non-invasive, non-contact optical coherence tomography angiography scans of the retina are done per built-in device protocol using the Zeiss Cirrus HD OCT 5000 AngioPlex machine.

Sponsors

Semmelweis University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy patients without eye disease

Exclusion criteria

* incapacity * any history or clinical evidence of retinal disease or glaucoma * previous ocular surgery or laser photocoagulation * optical media opacities that would disturb imaging

Design outcomes

Primary

MeasureTime frameDescription
Skeleton density (SD) measured by Angioplex MetrixThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex measurement done by built-in non-disclosed SD algorithm owned by Zeiss.
Vessel density (VD) measured by Mexican Hat filtering techniqueThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex, images are transferred to ImageJ and proportion of the vessels and the total image area (white pixels2/total number of pixels2) is calculated using Mexican Hat filtering technique.
Skeleton density (SD) measured by Mexican Hat filtering techniqueThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex, images are transferred to ImageJ and length of blood vessels (white skeletonized pixels/total number of pixels2) is calculated using Mexican Hat filtering technique.
Vessel diameter index (VDI) measured by Mexican Hat filtering techniqueThrough study completion, 1 yearRepresents the average vessel caliber (two dimensional white pixels in the binarized image/one dimensional white pixels in the skeletonized image or VD/SD) using Mexican Hat filtering technique.
Vessel density (VD) measured by Shanbag tresholding techniqueThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex, images are transferred to ImageJ and proportion of the vessels and the total image area (white pixels2/total number of pixels2) is calculated using Shanbag tresholding technique.
Skeleton density (SD) measured by Shanbag tresholding techniqueThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex, images are transferred to ImageJ and length of blood vessels (white skeletonized pixels/total number of pixels2) is calculated using Shanbag tresholding technique.
Vessel diameter index (VDI) measured by Shanbag tresholding techniqueThrough study completion, 1 yearRepresents the average vessel caliber (two dimensional white pixels in the binarized image/one dimensional white pixels in the skeletonized image or VD/SD) using Shanbag tresholding technique.
Vessel density (VD) measured by Angioplex MetrixThrough study completion, 1 yearFollowing standard OCTA imaging with Zeiss Cirrus Angioplex measurement is done by built-in non-disclosed VD algorithm owned by Zeiss.

Secondary

MeasureTime frameDescription
Comparison of results obtained by the three quantification techniquesThrough study completion, 1 yearComparison of VD and SD (see above) obtained by Mexican Hat filtering technique, Shanbag tresholding technique and built-in Zeiss proprietary algorithm.

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026